SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 257 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $172,778 | -51.7% | 6,459 | -38.4% | 0.02% | -46.7% |
| Q1 2024 | $357,814 | +95.8% | 10,490 | +66.1% | 0.04% | +25.0% |
| Q4 2023 | $182,727 | +373.1% | 6,314 | +350.7% | 0.04% | +227.3% |
| Q3 2023 | $38,626 | +80.0% | 1,401 | +96.2% | 0.01% | +57.1% |
| Q2 2023 | $21,463 | -19.2% | 714 | -2.6% | 0.01% | -22.2% |
| Q1 2023 | $26,557 | +35.6% | 733 | +33.5% | 0.01% | +12.5% |
| Q4 2022 | $19,583 | +15.2% | 549 | +9.6% | 0.01% | +14.3% |
| Q3 2022 | $17,000 | – | 501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
| ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
| S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
| Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
| Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
| Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
| Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |